News About: Pharm. Industry
Complaint filed against BMS Korea over illegal employment of other salespersons
The labor union of BMS Korea on Thursday filed a complaint against the company for illegally hiring salespersons from Inventive Health Korea.
The union said in a statement that they filed the complaint with the Kan...
Kwangdong’s oral film-type drug gains popularity at pharmacy
Kwangdong Pharmaceutical’s Cool Strip (cetylpyridinium chloride), an oral film-type troche for the treatment of stomatitis, has enjoyed a big popularity at pharmacies.
The company said Friday that it sold more than...
Labor dispute looms large at BMS Korea
BMS Korea and unionists are on a collision course over BMS's outsourcing of their products to a local marketing agency.
The union said it will launch a campaign against the company management unless they drop a pla...
5 doctors caught in rebate crackdown
Five doctors in Gil Hospital were found to have received rebates from a pharmaceutical firm, the government investigation team said Thursday.
The team, led by the Incheon Police Office, also indicted two salesperso...
Celgene Korea urged to further reduce insurance price of Revlimid
Celgene is still in a tug of war with the Health Insurance Review and Assessment Service (HIRA) to make its cancer drug Revlimid more affordable to the national health insurance, although the company already reduced t...
Multinational drug firms increase market share
With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.
According to the data comp...
Lipitor sales top 31.1 billion won in first half
Pfizer’s Lipitor posted 31.1 billion won in its first-half sales in domestic prescription drugs market, strengthening its supremacy as Korea’s leading anti-arteriosclerosis agent, according to data compiled by Yakup.c...
What makes Green Cross’s Shinbaro promising drug?
Osteoporosis is a massive concern for older women. Standard current treatments for osteoporosis can reduce bone fractures significantly. But they have been associated with a range of side effects, including stomach an...
Local impotence drug market to reach 150 billion won in size
Korean pharmaceutical firms are gearing up to enter the current 100 billion won anti-impotence drug market as the main patent of the market leader, Pfizer’s Viagra, expired on May 18.
According to the Korea Food an...
Handok, Genexine joins forces in novel human growth hormone
Handok Pharmaceutical and Genexine, a drug development biotech, have agreed to join hands to develop Generxine’s next-generation human growth hormone.
Under the deal, both companies will make efforts to commerciali...
